文献速递重症综合管理与镇静镇痛

重症患者住院前后5年精神障碍治疗患病率及精神药物使用的变化:加拿大基于人群的研究

The 5-year pre- and post-hospitalization treated prevalence of mental disorders and psychotropic medication use in critically ill patients: a Canadian population-based study.
PubMed 文献 · Intensive Care Med · 2021-09-08
一句话结论ICU幸存者出院后5年精神障碍治疗患病率从41.5%升至55.6%,且高于非ICU住院及一般人群,应关注ICU后精神健康。

该研究利用加拿大曼尼托巴省行政数据库,纳入2000-2012年49,439例ICU患者,并与146,968例非ICU住院患者及141,937例一般人群匹配比较。测量住院前后5年精神障碍治疗患病率和精神药物处方。ICU人群5年治疗患病率从住院前41.5%升至出院后55.6%;出院后1年调整患病比(APR)较非ICU住院患者为1.08(95%CI 1.05-1.11),5年为1.03(95%CI 1.01-1.05)。ICU暴露与心境、焦虑、精神病性障碍及镇静催眠药使用增加相关。

要点

  • ICU幸存者出院后5年精神障碍治疗患病率达55.6%,较住院前41.5%显著增加。
  • 出院后1年精神障碍治疗患病率较非ICU住院患者高8%(APR 1.08, 95%CI 1.05-1.11)。
  • ICU暴露与心境、焦虑、精神病性障碍及镇静催眠药使用增加相关(Time×Group交互p<0.0001)。
  • ICU患者在住院前后均高比例接受抗抑郁药、抗焦虑药及镇静催眠药处方。
  • 建议对重症幸存者开展精神障碍识别与治疗项目,但需进一步研究验证。

适用人群与场景

  • 2000-2012年加拿大曼尼托巴省ICU住院患者49,439例,与非ICU住院患者146,968例及一般人群141,937例匹配比较。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于人群的回顾性行政数据库队列研究,单省(曼尼托巴)数据,ICU组49,439例,非ICU住院对照组146,968例,一般人群对照组141,937例。
  • 主要结果:ICU人群5年精神障碍治疗患病率住院前41.5%,出院后55.6%。
  • 与非ICU住院患者比较:住院前1年APR 0.94(95%CI 0.92-0.97, p<0.0001),5年APR 0.99(95%CI 0.98-1.00, p=0.1);出院后1年APR 1.08(95%CI 1.05-1.11, p<0.0001),5年APR 1.03(95%CI 1.01-1.05, p<0.0001)。
  • 多变量分析:ICU暴露与心境、焦虑、精神病性障碍及镇静催眠药使用增加相关(Time×Group交互p<0.0001)。

证据类型、等级与局限

  • 证据类型:基于行政数据库的回顾性队列研究;证据等级原文未提及;局限:单中心省份数据,依赖行政诊断编码,可能低估未治疗的精神障碍,观察性设计不能证明因果。

对床旁实践的改变

  • 提示ICU幸存者出院后精神障碍治疗患病率及精神药物使用显著增加,应加强ICU后精神健康筛查与随访;但原文未提供具体筛查工具、干预措施或药物方案。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: The interplay between critical illness and mental disorders is poorly understood. The purpose of this study is to measure both the treated prevalence of mental disorders and psychotropic medication use before and after hospitalization and the impact of intensive care unit (ICU) admission on these outcomes.

METHODS: Using a population-based administrative database in Manitoba, Canada, 49,439 ICU patients admitted between 2000 and 2012 were compared to two matched comparison groups (hospitalized; n = 146,968 and general population; n = 141,937). Treated prevalence of mental disorders and psychotropic medication prescriptions were measured in the 5-year periods before and after the hospitalization. Multivariable models compared adjusted prevalence ratios (APRs) between populations.

RESULTS: The 5-year treated mental disorder prevalence in the ICU population increased from 41.5% pre-hospitalization to 55.6% post-hospitalization. Compared to non-ICU hospitalized patients, the adjusted treated mental disorder prevalence in ICU patients was lower prior to hospitalization (1-year APR 0.94, 95% CI 0.92-0.97, p < 0.0001; 5-year APR 0.99, 95% CI 0.98-1.00, p = 0.1), but higher following discharge (1-year APR 1.08, 95% CI 1.05-1.11, p < 0.0001, 5-year APR 1.03, 95% CI 1.01-1.05, p < 0.0001). A high proportion of ICU patients received antidepressant, anxiolytic and sedative-hypnotic prescriptions before and after their hospitalization. In multivariable analyses, ICU exposure was associated with an increase in mood, anxiety and psychotic disorders, and sedative-hypnotics use (p < 0.0001 for all Time × Group interactions).

CONCLUSIONS: During the 5 years after admission to ICU, there is a significant increase in treated prevalence of mental disorders and psychotropic medication use compared to the 5 years prior to ICU and compared to general population and hospital cohorts. Prevention and intervention programs that identify and treat mental disorders among survivors of critical illness warrant further study.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Olafson K, Marrie RA, Bolton JM, et al. The 5-year pre- and post-hospitalization treated prevalence of mental disorders and psychotropic medication use in critically ill patients: a Canadian population-based study. Intensive Care Med. 2021. PMID: 34495357. doi:10.1007/s00134-021-06513-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。